№ lp_1_2_25630
File format: docx
Character count: 2460
File size: 20 KB
A position statement regarding the use of doxycycline during pregnancy, including its safety in the first trimester and recommendations for alternative treatments.
Year:
2024
Region / City:
United Kingdom
Subject:
Doxycycline use during pregnancy
Document type:
Position statement
Organization / Institution:
BASHH (British Association for Sexual Health and HIV)
Author:
Ali Grant; on behalf of BASHH Clinical Effectiveness Group (CEG)
Target audience:
Healthcare professionals
Effective period:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2025
Region / City:
United Kingdom
Theme:
Genitourinary Medicine, Sexual Health
Document Type:
Clinical Guideline
Organization:
British Association for Sexual Health and HIV (BASHH)
Author:
Sarah K Edwards, Pareswaran Shashidharan, Imali Fernanado, Georgina Morris, Dayan Vijeratnum, Jason Eng Kiat Lim, Deepa Grover
Target Audience:
Healthcare professionals working in sexual health services
Period of Validity:
Ongoing, with formal reviews every 5 years
Approval Date:
August 2025
Date of Last Review:
August 2020
Date of Last Update:
August 2025
Year:
2025
Region / City:
United Kingdom
Topic:
Undergraduate Prizes in Medical and Clinical Research
Document Type:
Regulations
Organization / Institution:
BASHH (British Association for Sexual Health and HIV)
Author:
BASHH Education Committee
Target Audience:
Undergraduate students in medicine or related fields
Start Date:
Not specified
End Date:
Not specified
Approval Date:
Not specified
Amendment Date:
March 2025
Year:
2026
Region / City:
Not specified
Topic:
Conflict of interest in clinical guideline development
Document Type:
Declaration
Organization / Institution:
BASHH (British Association for Sexual Health and HIV)
Author:
BASHH Clinical Effectiveness Group (CEG)
Target Audience:
Members of the BASHH CEG and guideline authors
Validity Period:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2025
Region / City:
Massachusetts
Topic:
Lyme Disease, Postexposure Prophylaxis
Document Type:
Medical Guideline
Organization / Institution:
Massachusetts Department of Public Health
Author:
Massachusetts Department of Public Health
Target Audience:
Healthcare providers
Period of Effectiveness:
July 14, 2025
Approval Date:
July 14, 2025
Date of Changes:
N/A
Doxycycline 100mg Capsules Initial Supply for Tularemia Patient Group Direction (PGD), Version 6.00a
Publications reference number:
PRN01582
Reference:
Doxycycline 100mg capsules PGD initial supply tularemia
Version number:
6.00a
Valid from:
1 October 2024
Review date:
1 March 2027
Expiry date:
30 September 2027
Developed by:
UK Health Security Agency (UKHSA)
Legal framework:
Human Medicines Regulations 2012 (HMR2012), Schedule 16 Part 2
Type of document:
Patient Group Direction (PGD)
Medicinal product:
Doxycycline 100mg capsules
Indication:
Initial supply following known or suspected deliberate release of tularemia
Eligible population:
Adults and children aged 12 years and over not showing symptoms compatible with tularemia infection
Exclusion criteria:
Under 12 years, no valid consent, known severe hepatic impairment, taking enzyme inducing antiepileptics
Authorising organisations:
NHS organisations and commissioners in accordance with HMR2012
Record retention requirement:
25 years after PGD expiry
Change history latest update:
Correction of typo and mail hyperlink to [email protected]
Note:
on 4 November 2024
Developed by (named professional):
Kiran Attridge, Senior Medical Adviser
Year:
2024
Institution:
Utrecht University; Wageningen University & Research
Type:
Master of Science research project
Supervisor:
Dr. Y.R.A. van Zeeland; Dr. R. Gehring; Dr. M. Heijne
Student:
T. Ploegers
Study period:
August 2019 – August 2020
Species studied:
Budgerigars and other avian species
Sample types:
Fecal and serum samples
Treatment methods:
Oral and intramuscular doxycycline
Objective:
Investigate residual excretion and pharmacokinetics of doxycycline
Ethical approval:
License AVD1080020184847 by CCD for university-collected samples
Source of field cases:
Dutch Food and Consumer Product Safety Authority (NVWA)
Version:
Final
Date:
August 4, 2024
Scope:
Zoonotic disease psittacosis, avian pharmacokinetics
Year:
2024
Region / City:
UK
Topic:
Antimicrobial Prescribing, Antibiotics, Guidelines
Document Type:
Guidelines
Institution:
NICE (National Institute for Health and Care Excellence), UKHSA
Author:
National OptimiseRx Team
Target Audience:
Healthcare Professionals, Prescribers
Period of Validity:
November 2024
Approval Date:
November 2024
Date of Changes:
November 2024
Year:
2021
Country:
Global
Topic:
COVID-19 vaccination during pregnancy
Document Type:
Supplementary material
Study Type:
Systematic review
Authors:
Not specified
Target Audience:
Researchers, healthcare professionals, policy makers
Period of validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2023
Region / City:
United Kingdom
Topic:
Medical Testing, Pregnancy Detection
Document Type:
Standard Operating Procedure (SOP)
Organization:
POCT
Author:
Rachel Lampard
Target Audience:
Clinical Staff
Approval Date:
N/A
Review Interval:
2 years
Changes from last version:
First entry to Q-pulse
Date of Approval:
N/A
Date of Changes:
N/A
Type of document:
Official information for health professionals
Topic:
Respiratory syncytial virus vaccination in pregnancy
Vaccine name:
Abrysvo®
Target population:
Pregnant women
Gestational age for administration:
28–36 weeks of pregnancy
Country:
Australia
Health program:
National Immunisation Program
Availability under NIP:
From 3 February 2025
Notifiable disease status:
RSV notifiable in Victoria since 22 February 2022
Regulatory authority:
Therapeutic Goods Administration
Monitoring scheme:
Black Triangle Scheme
Related legislation:
Public Health and Wellbeing Act 2008
Intended audience:
Health professionals
Storage requirements:
+2°C to +8°C
Year:
2017
Region / City:
Washington, DC
Theme:
Public Health, Health IT, Zika Virus
Document Type:
Report
Organization / Institution:
Health IT Policy Committee (HITPC), Health IT Standards Committee (HITSC), Department of Health and Human Services
Author:
Public Health Task Force
Target Audience:
Public health professionals, health IT developers, clinicians
Period of Effectiveness:
2017
Approval Date:
March 8, 2017
Date of Changes:
Not specified
Year:
2019
Region / City:
N/A
Subject:
Pregnancy tracking in Treatment Episode Data Set
Document Type:
Requirements Document
Organization:
DCF
Author:
Jesse Lindsey
Target Audience:
FEI Business Analysts, DCF SAMH Project Team
Period of Validity:
N/A
Approval Date:
03/17/2019
Modification Date:
03/21/2019
Year:
2021
Region / city:
Australian Capital Territory
Topic:
Hypertension, Pregnancy, Maternity Care
Document Type:
Guideline
Author:
Canberra Health Services
Target Audience:
Medical officers, Registered Midwives, Nurses, Allied Health professionals, Students working under supervision
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2024
Region / City:
Canberra
Topic:
Diabetes Management in Pregnancy
Document Type:
Guideline
Organization:
Canberra Health Services
Author:
Australasian Diabetes in Pregnancy Society (ADIPS)
Target Audience:
Healthcare providers (medical officers, nurses, midwives)
Period of validity:
Not specified
Approval Date:
Not specified
Date of last update:
November 2024
Year:
2023
Region / city:
Canberra, Australia
Topic:
Obstetrics, Pre-eclampsia, Pregnancy Care
Document type:
Guideline
Organization / institution:
Canberra Health Services
Author:
Society of Obstetric Medicine Australia and New Zealand (SOMANZ)
Target audience:
Medical Officers, Registered Nurses, Registered Midwives, Students, Pharmacists
Period of validity:
Not specified
Approval date:
2023
Date of amendments:
Not specified
Year:
2026
Location:
North Canberra Hospital, Canberra, Australia
Document type:
Procedure
Department:
Canberra Health Services – Maternity Unit and Medical Imaging
Audience:
Medical Officers, Nurses, Midwives, Medical Imaging staff
Scope:
Pregnancy ultrasound eligibility and bedside ultrasound use in maternity care
Attachments:
CHS Preterm Birth Prevention – Management of Moderate-Risk Patients Pathway; Fetal Growth Restriction (FGR) care pathway for singleton pregnancies
Related policies:
Maternal Fetal Medicine Unit referrals, clinical guidelines for prenatal imaging
Reference:
CHS25/004 Procedure Document
Note:
Year
Topic:
Medical Diagnostics
Document Type:
Standard Operating Procedure (SOP)
Organization:
Siemens
Author:
Jane Mason
Target Audience:
Medical professionals
Period of Use:
Indefinite
Year:
2023
Region / City:
United Kingdom
Topic:
Student support, maternity, pregnancy
Document Type:
Policy
Institution:
University of Oxford
Author:
Not specified
Target Audience:
Students, academic staff
Period of Validity:
Ongoing
Approval Date:
Not specified
Date of Amendments:
Not specified
Year:
2023
Region / City:
Canberra
Topic:
Obesity and its impact on pregnancy and childbirth
Document Type:
Guideline
Organization:
Canberra Health Services
Author:
Not specified
Target Audience:
Medical Officers, Registered Midwives, Students under direct supervision
Effective Period:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2023
Region / City:
Canberra
Topic:
Hyperemesis Gravidarum, Pregnancy Care
Document Type:
Procedure
Organization:
Canberra Health Services
Author:
Not specified
Target Audience:
Clinical staff at CHS, external referrers, medical and nursing professionals
Period of Application:
Ongoing
Approval Date:
Not specified
Amendment Date:
Not specified